Invention Grant
- Patent Title: Pharmaceutical agents targeting cancer stem cells
-
Application No.: US16082288Application Date: 2017-03-07
-
Publication No.: US10888549B2Publication Date: 2021-01-12
- Inventor: Mohammad O. Hoque , David Sidransky , Akira Oki
- Applicant: THE JOHNS HOPKINS UNIVERSITY
- Applicant Address: US MD Baltimore
- Assignee: THE JOHNS HOPKINS UNIVERSITY
- Current Assignee: THE JOHNS HOPKINS UNIVERSITY
- Current Assignee Address: US MD Baltimore
- Agency: Johns Hopkins Technology Ventures
- International Application: PCT/US2017/021073 WO 20170307
- International Announcement: WO2017/155935 WO 20170914
- Main IPC: A61K31/33
- IPC: A61K31/33 ; A61K31/415 ; A61K31/40 ; A61K31/409 ; A61K31/407 ; A61P35/00 ; A61K31/635 ; A61K45/06

Abstract:
Methods for preventing or treating subjects having cancer based on the identification of pharmaceutical agents that target cancer stem cells (CSCs) have been identified. These methods include administering to the subject an effective amount of a COX2 inhibitor and an effective amount of a YAP1 inhibitor. In addition, methods of enhancing chemotherapeutic responses in cancer patients have been discovered and are described herein.
Public/Granted literature
- US20190091202A1 PHARMACEUTICAL AGENTS TARGETING CANCER STEM CELLS Public/Granted day:2019-03-28
Information query